Vision

Leading automation and intelligence technologies enable breakthrough innovations and productivity revolution, engineering a more efficient, vivid and beautiful world.

ABOUT MEGAROBO

Founded in 2016, MEGAROBO is a science and technology company specializing in providing advanced productivity tools for life sciences, clinical diagnostics and applied chemistry industries. MEGAROBO is dedicated to leveraging robotic automation and AI technologies to accelerate productivity revolution and innovation breakthroughs, to engineer a more efficient, vivid, and beautiful world.


MEGAROBO provides innovative intelligent automation products and solutions of high quality for the life sciences industry, covering R&D, production and detection. With the research capabilities of MegaLab, the self-developed intelligent biological laboratory, MEGAROBO provides high-value productivity tools and services, accelerating the intelligent automation revolution in new drug discovery, cell and gene therapy, organoids and synthetic biology, ultimately improving human health.


MEGAROBO values independent development and technological innovation, and assembles over 1000 interdisciplinary professionals, with 60% dedicated to R&D. MEGAROBO has filed nearly 600 patents, demonstrating our expertise in multiple core technologies with global competitive capabilities. The global headquarters is in Singapore. MEGAROBO owns sites in Beijing, Shanghai, Shenzhen and Suzhou, and globalised in the United States, the United Kingdom and Japan.


MEGAROBO has closed its Series C financing round. And MEGAROBO got long-term support from key investors including WuXi AppTec, Bosch, Sino Biological, Goldman Sachs Asset Management, Asia Investment Capital, Sinovation Ventures, Joy Capital, Matrix Partners China, and Pavilion Capital.


Our Team

  • 1000+

    Employees

  • 60%

    R&D personnel

  • 60%

    Master degree or above

  • 40%

    Interdisciplinary talents

  • 550+

    Patent applications

Milestone

2016

June
Founded in Beijing
Pioneer in life sciences automation solutions market

2017

June
Angel round

2018

November
Suzhou delivery center started operation

2019

April
Series A/A+ rounds led by BOSCH
December
MagaRobo’s life sciences lab in operation
Entered into life sciences research services market

2020

August
Developed world’s first high-throughput sample processing and RNA extraction instruments for Covid PCR test
November
Shenzhen delivery center started operation

2021

May
Series B1/B2/B3 rounds led by Sinovation Ventures/Matrix Partners /WuXi AppTec
August
MegaLab phase I by MEGAROBO established in Beijing
September
Intelligent genetic engineering lab established in Shanghai
Entered into cell and gene therapy solution services market
December
MEGAROBO's annual output value exceeds 400 million yuan

2022

April
Series C round led by Goldman Sachs, Asia Investment Capital
June
Head offices in Singapore, US and Japan established
Global expansion initiated

2023

May
MegaLab 2.0 construction commenced

GLOBAL FOOTPRINT


QUALIFICATIONS AND HONORS


ISO13485(BEIJING)

ISO13485(SUZHOU)

ISO 9001

EU DOC Certification

UDEM Certification

UKCA Certification

National High-Tech Enterprise(BEIJING)

National High-Tech Enterprise(SUZHOU)

National High-Tech Enterprise(SHENZHEN)

Beijing Technologically Advanced ‘Little Giant’ Enterprises

Jiangsu Specialized and Sophisticated SMEs

Shenzhen Specialized and Sophisticated SMEs

Deloitte China Technology Fast 50

MIT Technology Review - 50 Smartest Companies in China 2021

Deloitte China Rising Star 2020

DNA Paris Design Awards 2022

Spark Design Awards 2021

IDA Design Awards 2021

Contemporary Good Design Award 2021